Critical Challenges in
Cardiovascular Medicine

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

February 1, 2008

Expiration Date:

February 1, 2010

Intended Audience:

This symposium is designed for emergency medicine specialists, program directors, cardiologists, emergency medicine nurses, PAs, NPs, prehospital care providers, pharmacists, and other healthcare providers caring for patients with acute cardiovascular disease.

Registration:

Enrollment for this webcast is complimentary, and clinicians are invited to attend this CME-certified symposium and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent educational grant from The Medicines Company, Inc.

Accreditation Statement for Jointly-Sponsored Programs:

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 3 AMA PRA Category 1 Credit(s)^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Charles V. Pollack, MD, FACEP
Grant/Research Support: GlaxoSmithKline
Consultant: The Medicines Company, Schering-Plough, Sanofi-Aventis, BMS, Genentech
Speaker’s Bureau: Schering-Plough, Sanofi-Aventis, BMS, Genentech

Steven V. Manoukian, MD, FACC
Grant/Research Support: The Medicines Company
Speaker’s Bureau: The Medicines Company

Judd E. Hollander MD
Grant/Research Support: Sanofi-Aventis, Biosite, Scios, The Medicines Company
Consultant: Sanofi-Aventis, Biosite, Scios, The Medicines Company
Speaker’s Bureau: Sanofi-Aventis, Biosite, Scios, The Medicines Company

Program Faculty:

Charles V. Pollack , MD, FACEP
(Program Chairman)
Chairman, Department of Emergency Medicine
Pennsylvania Hospital
Professor of Emergency Medicine
University of Pennsylvania School of Medicine
Philadelphia, PA

Steven V. Manoukian , MD, FACC
Director, Interventional Cardiology
Emory-Crawford Long Hospital
Emory University School of Medicine
President, American Heart Association,
Atlanta Div.

Judd E. Hollander , MD
Professor and Clinical Research Director
Department of Emergency Medicine
University of Pennsylvania
Philadelphia, PA

Educational Objectives:

• As a result of this session, attendees are able to assess and implement optimal antithrombotic strategies for patients with NSTEMI and STEMI.
• As a result of this session, attendees will understand impact of specific pharmacologic agents on outcomes, including ischemic endpoints, bleeding, and mortality for patients with ACS.
• As a result of this session, attendees are able to discuss the impact that new trials are likely to have on future management of patients with ACS.
• As a result of this session, ED physicians will learn to apply AHA/ACC, ACCP, and other national guidelines in order to optimize therapy ACS.

Disclaimer:

Copyright © 2007 by Pharmatecture, LLC. All rights reserved.
Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this WebCAST reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this WebCAST is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this WebCAST is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This WebCAST is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This WebCAST is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright (c) 2007 All rights reserved